Literature DB >> 26071440

Phenytoin as an effective treatment for polymorphic ventricular tachycardia due to QT prolongation in a patient with multiple drug intolerances.

Neil Yager1, Katherine Wang1, Najiba Keshwani1, Mikhail Torosoff1.   

Abstract

We present a case of a 69-year-old woman presenting with polymorphic ventricular tachycardia caused by QT prolongation. Owing to known intolerances to a majority of antiarrhythmic medications, one remaining option was to initiate phenytoin. Phenytoin's narrow therapeutic window, multiple drug interactions and side effect profile make it an infrequently used antiarrhythmic. It is, however, a potent antiarrhythmic agent, which may be useful in treatment of ventricular tachycardia, especially in patients with multiple drug intolerances. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26071440      PMCID: PMC4480099          DOI: 10.1136/bcr-2015-209521

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Review article: phenytoin use and efficacy in the ED.

Authors:  Katharine Gallop
Journal:  Emerg Med Australas       Date:  2010-04       Impact factor: 2.151

2.  Phenytoin: an old but effective antiarrhythmic agent for the suppression of ventricular tachycardia.

Authors:  Louis W Wang; Rajesh N Subbiah; Michael J Kilborn; Richard F Dunn
Journal:  Med J Aust       Date:  2013-08-05       Impact factor: 7.738

Review 3.  Pharmacological effects of antiarrhythmic drugs. Review and update.

Authors:  P R Kowey
Journal:  Arch Intern Med       Date:  1998-02-23

4.  Phenytoin in treatment of amiodarone-induced Torsades de pointes.

Authors:  Saibal Mukhopadhyay; Praloy Chakraborty; Jamal Yusuf; Anuj Goyal; Sanjay Tyagi
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

  4 in total
  3 in total

Review 1.  Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

2.  Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3.

Authors:  Reina Bianca Tan; Sujata Chakravarti; Melissa Busovsky-McNeal; Abigail Walsh; Frank Cecchin
Journal:  HeartRhythm Case Rep       Date:  2016-10-17

Review 3.  Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity.

Authors:  Sapan K Behera; Saibal Das; Kavadichanda G Chengappa; Alphienes S Xavier; Sandhiya Selvarajan
Journal:  Curr Clin Pharmacol       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.